Navigation Links
Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs
Date:7/22/2009

INDIANAPOLIS, July 22 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) announced today during a lease signing event that it has become the first tenant of New York City's new Alexandria Center for Science and Technology at East River Science Park, a development that shows tangible evidence that New York is positioning itself to become a hub for biopharmaceutical research. The biotech park -- located adjacent to the NYU Langone Medical Center in Manhattan -- will house ImClone's Research Division including approximately 125 ImClone scientists with plans to add scientists in those areas that support expansion of the ImClone pipeline. The new location enables unprecedented access to academic research organizations in the New York area. This move is consistent with Lilly's transformation into a fully integrated pharmaceutical network (FIPNet) in which it is increasingly collaborating with external organizations and companies to speed innovation to patients. Nearly 20 current FIPNet partners are located in proximity to the new location. ImClone's manufacturing, development and administrative operations will remain based in New Jersey.

Mayor Bloomberg is a major supporter of the move. "New York City has always been at the forefront of scientific innovation, but the City has never fully capitalized on its assets to create a thriving commercial bioscience industry and the jobs that come with it," said Mayor Bloomberg. "We set out to create the East River Science Park to provide today's bioscience companies with the state-of-the-art commercial lab space they need to locate and expand. Eli Lilly and Company's decision to become its anchor tenant is evidence that our work is paying off. It also serves as a major boost to our efforts to diversify New York City's economy. In recent months, we've announced init
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015 The Assistance Fund ... This program provides financial assistance for copay to individuals ... to announce the addition of the Melanoma Copay Assistance ... Mark McGreevy , executive director. "With each additional program ... of a world where no one is denied access ...
(Date:5/22/2015)... , May 22, 2015  RegeneRx Biopharmaceuticals, Inc. ... tissue protection, repair and regeneration, today announced that ... scheduled to present a corporate overview at two upcoming ... at the SeeThruEquity 4 th Annual Microcap Conference ... York City at 11:00 am EDT.  A ...
(Date:5/22/2015)...  The Mesothelioma Victims Center is incredibly passionate ... the best possible compensation, and they are also extremely ... cancer caused by exposure to asbestos or their ... treatment options such as a recent possible medical breakthrough. ... Center anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com ...
Breaking Medicine Technology:The Assistance Fund Adds Melanoma Assistance Program 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5
... Chindex International, Inc. (NASDAQ: CHDX ), ... China through the operations of United Family Healthcare, a network ... announced financial results for the third quarter and first nine ... Third Quarter 2011 Financial Highlights ...
...  Inova Labs, a privately held medical ... Chronic Obstructive Pulmonary Disease (COPD) market, announced today that ... financing for up to $17.5M from an investment syndicate ... Calif. The company plans to use the capital to ...
Cached Medicine Technology:Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 2Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 3Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 4Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 5Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 6Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 7Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 8Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 9Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 10Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 11Inova Labs Closes on $17.5M Series B Financing 2
(Date:5/23/2015)... On May 16, the team at ... a 5k mud obstacle run that raised funds for multiple ... worldwide, and the reason we participated was to support people ... of Farrell’s eXtreme Bodyshaping. “One-hundred percent of the funds raised ... event was not only attended by eXtreme Bodyshaping staff, but ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 A live auction ... equipment from hospitals, surgery centers and other medical facilities around ... sold including endoscopy, lab, radiology, surgery, anesthesia, exam and much ... May 27 and Thursday, May 28 starting at 9:00am CDT ... at 1400 N. 25th Avenue, Melrose Park, IL 60160. ...
(Date:5/23/2015)... Add High-Quality prismatic refractions into footage using ProFlare ... simple as dragging and dropping footage into the FCPX timeline ... , Including over 80 stunning flares, ProFlare 5K Prism ... the ultimate bundle for adding prismatic refractions to any video. ... movie files designed for Final Cut Pro X, but are ...
(Date:5/22/2015)... May 22, 2015 The world ... and capacity are intersecting to create new opportunities ... the opening speaker at WesternU's 34th annual Commencement ... Gov. Gavin Newsom, a former San Francisco mayor ... speaker at the graduation ceremony for WesternU's colleges ...
(Date:5/22/2015)... 2015 The American College of Traditional ... June. They will hold a webinar on the updates ... class on Classical Chinese Medicine. , Webinar – First ... Given, the Dean of Clinical Education, will lead this ... Professional Doctorate program. ACTCM is currently developing this degree ...
Breaking Medicine News(10 mins):Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2Health News:Developers at Pixel Film Studios Release ProFlare 5K Prism for Final Cut Pro X. 2Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:ACTCM Announces Upcoming June Events 2
... with muscle-thickening disorder may also identify children at risk ... 10 gene mutations responsible for cardiac hypertrophy (thickening of ... many cases of this rare but life-threatening condition in ... showed up in children who had no family history ...
... Muneo Takashi has been,named to head the Chicago ... As the new Chief Executive Director, Takashi follows ... assignment in Chicago., As Chief Executive Director, ... activities designed to facilitate business development,between Japan and ...
... Tripled dose was ineffective and toxic, so strategy should ... News) -- High-intensity chemotherapy does not improve the survival ... a new Swiss study concludes. , Testing on 140 ... differences in survival rate or tumor size between groups ...
... Researchers at Boston College have developed the first laboratory ... Using their novel cell line, the team discovered one of ... attack. , The development of a new animal model ... that displays the full spectrum of systemic metastatic cancer ...
... remains,underdiagnosed and undertreated even though this neurologic ... options have increased in the,last decade., ... treat this neurologic,sleep disorder, The Journal of ... supplement "Stay awake! Understanding, diagnosing, and,successfully managing ...
... 9 United Heartland is pleased to,announce that ... of,Community Providers has earned a record dividend of ... performance of the group,s 48 members, which,achieved an ... http://www.newscom.com/cgi-bin/prnh/20080409/CLW076LOGO ), The Iowa Association of ...
Cached Medicine News:Health News:Gene Mutations for Rare Heart Disease Also Found in Kids 2Health News:Muneo Takashi Named Chief Executive Director of Japan's Midwest Trade Office 2Health News:High-Dose Chemo Fails Against Small Cell Lung Cancers 2Health News:Boston College biologists build a better mouse model for cancer research 2Health News:United Heartland Group Program Earns Record Dividend 2
Bailey lachrymal cannula, 7 mm exposed tip, 8 mm reinforced....
Lachrymal cannula, straight....
Shahinian lacrimal cannula, bullet shaped tip, 0.3 mm side opening, straight....
Solo-care is a multi-purpose solution for cleaning, rinsing, disinfection and storing soft contact lenses....
Medicine Products: